Accord BioPharma, the specialty branch of Intas Pharmaceuticals, Ltd. in the United States, aims to deliver cost-effective, accessible, patient-focused treatments in the fields of oncology, immunology, and critical care. The company is dedicated to enhancing the patient experience by looking at diseases from the patient's viewpoint and creating high-standard therapies that have a positive impact on the lives of patients.